The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-methoxyphenethyl)-4-(2-ethoxyphenyl)piperazine ID: ALA3947302
PubChem CID: 134147929
Max Phase: Preclinical
Molecular Formula: C21H28N2O2
Molecular Weight: 340.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1ccccc1N1CCN(CCc2cccc(OC)c2)CC1
Standard InChI: InChI=1S/C21H28N2O2/c1-3-25-21-10-5-4-9-20(21)23-15-13-22(14-16-23)12-11-18-7-6-8-19(17-18)24-2/h4-10,17H,3,11-16H2,1-2H3
Standard InChI Key: MLGVJRUWZGCRQT-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
4.6897 -7.9930 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4066 -8.3920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1077 -7.9739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0960 -7.1568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3832 -6.7578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6821 -7.1759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8012 -6.7387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5140 -7.1377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2151 -6.7196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2034 -5.9025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4906 -5.5035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7895 -5.9216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5216 -7.9548 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2343 -8.3537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9886 -8.4111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2758 -8.0122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1567 -8.4453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1684 -9.2624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8812 -9.6655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5864 -9.2474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5747 -8.4303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8619 -8.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4438 -8.0453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2595 -8.4615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9366 -7.9358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
13 14 1 0
8 13 1 0
4 7 1 0
15 16 1 0
17 18 1 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
18 19 2 0
16 21 1 0
1 15 1 0
23 24 1 0
17 23 1 0
14 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.47Molecular Weight (Monoisotopic): 340.2151AlogP: 3.46#Rotatable Bonds: 7Polar Surface Area: 24.94Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.79CX LogP: 3.98CX LogD: 3.44Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.77Np Likeness Score: -1.28
References 1. Silva RO, de Oliveira AS, Nunes Lemes LF, de Camargo Nascente L, Coelho do Nascimento Nogueira P, Silveira ER, Brand GD, Vistoli G, Cilia A, Poggesi E, Buccioni M, Marucci G, Bolognesi ML, Romeiro LAS.. (2016) Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor., 122 [PMID:27448917 ] [10.1016/j.ejmech.2016.06.052 ]